Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.

Author: , AiyegbusiOlalekan Lee, AllevaEugenia, BarlettaFrancesco, BeyerKatharina, BrigantiAlberto, CornfordPhilip, DereviankoAlexandra, FurnariFederica, GandagliaGiorgio, LeardiniLuca, MacLennanSara J, MacLennanSteven, Mazzoleni FerraciniSerena, MossCharlotte, MottetNicolas, N'DowJames, OmarMuhammad Imran, PellegrinoFrancesco, RattiMaria Monica, ScuderiSimone, SiscaElena Silvia, SorceGabriele, Van HemelrijckMieke, WilliamsonPaula R, ZongJihong

Paper Details 
Original Abstract of the Article :
Prostate cancer (PCa) is the second most common cancer among men worldwide. Urinary, bowel, and sexual function, as well as hormonal symptoms and health-related quality of life (HRQoL), were prioritised by patients and professionals as part of a core outcome set for localised PCa regardless of treat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.euo.2021.10.004

データ提供:米国国立医学図書館(NLM)

Prostate Cancer: A Shared Journey Towards Better Outcomes

This study explores the importance of standardizing patient-reported outcome measures (PROMs) for localized prostate cancer (PCa) treatment. It's like a caravan of patients facing a difficult journey through the desert of treatment – we need to ensure everyone has a clear understanding of the potential outcomes and challenges.

The study found that patients and healthcare professionals agree that PROMs should include urinary, bowel, and sexual function, hormonal symptoms, and health-related quality of life (HRQoL) regardless of the chosen treatment. This consensus provides a framework for measuring the impact of PCa treatments on a patient's well-being.

Measuring Success: A Shared Compass

This research emphasizes the importance of using standardized PROMs to assess the impact of PCa treatments. It's like using a shared compass to ensure everyone is navigating the same path and making informed decisions.

Navigating the Treatment Landscape

This study encourages a more patient-centered approach to PCa treatment. By standardizing PROMs, we can better understand the impact of treatments on patients' lives and ultimately work towards better outcomes.

Dr.Camel's Conclusion

Standardizing PROMs for prostate cancer treatment is a crucial step in ensuring that patients have a shared understanding of the potential benefits and challenges of different treatment options. It's like providing a reliable map for navigating the complex desert landscape of PCa treatment.

Date :
  1. Date Completed 2022-05-12
  2. Date Revised 2022-05-16
Further Info :

Pubmed ID

34785188

DOI: Digital Object Identifier

10.1016/j.euo.2021.10.004

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.